NCT00052884 2023-06-18
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Eastern Cooperative Oncology Group
Phase 1 Terminated
Clinical Trials
1 trialsDrug-Related Side Effects and Adverse Reactions × Peripheral Blood Stem Cell Transplantation × Plasma cell × Clear all